Fund shareholders of Zevra Therapeutics Inc
ISIN US4884452065 · United States · LEI 254900CU6T74V18Y1W18
- Fund shareholders
- 130
- Of which ETFs
- 23 107 other funds
- Value held
- 110.4M $
- Share of capital
- 19.8 % of 59.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares UltraPro Russell2000 ProShares Trust | 3,437 | 30.7K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,283 | 33.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,142 | 28.1K $ | 0.04 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,600 | 23.2K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 2,443 | 24.8K $ | 0.74 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 2,414 | 21.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 2,122 | 19.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,080 | 18.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 1,856 | 17.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,687 | 15.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,448 | 13.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 1,400 | 13K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 1,292 | 12K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,220 | 10.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 1,188 | 12.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 996 | 9.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 628 | 6.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 597 | 5.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 339 | 3.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 301 | 3.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 277 | 2.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 186 | 1.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 141 | 1.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 127 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 102 | 1K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 86 | 801.5 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 76 | 708.3 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 57 | 509 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 16 | 142.9 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 139.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 1.29 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.98 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.94 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.75 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.74 % | as of Apr 30, 2026 ↗ |
| Simplify Piper Sandler US Small-Cap PLUS Income ETF Simplify Exchange Traded Funds | 0.71 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Small Cap Core ETF Federated Hermes ETF Trust | 0.14 % | as of Feb 28, 2026 ↗ |
| JPMorgan U.S. Small Company Fund JPMorgan Trust I | 0.14 % | as of Mar 31, 2026 ↗ |
| LVIP JPMorgan Small Cap Core Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.14 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Fund ROYCE FUND | 0.14 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 130 | +4 | 11,733,982 | +10.0 % |
| 2026Q1 | 126 | +16 | 10,664,848 | +13.8 % |
| 2025Q4 | 110 | +6 | 9,369,783 | -0.1 % |
| 2025Q3 | 104 | -9 | 9,375,678 | -3.3 % |
| 2025Q2 | 113 | +5 | 9,693,182 | +1.1 % |
| 2025Q1 | 108 | +6 | 9,583,510 | +12.0 % |
| 2024Q4 | 102 | +14 | 8,559,492 | +84.0 % |
| 2024Q3 | 88 | +1 | 4,650,647 | +5.2 % |
| 2024Q2 | 87 | +6 | 4,420,854 | +2.1 % |
| 2024Q1 | 81 | -6 | 4,331,523 | +4.6 % |
| 2023Q4 | 87 | 4,139,107 |
Institutional managers
142 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 4,456,476 | 41.5M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 3,450,943 | 32.2M $ | as of Mar 31, 2026 |
| FMR LLC | 3,211,877 | 29.9M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 2,521,936 | 23.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,561,569 | 14.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,371,857 | 12.8M $ | as of Mar 31, 2026 |
| AIGH Capital Management LLC | 1,200,000 | 11.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,192,262 | 11.1M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,163,090 | 10.8M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 1,157,131 | 10.8M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 988,674 | 9.2M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 975,000 | 9.1M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 846,457 | 7.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 842,319 | 7.9M $ | as of Mar 31, 2026 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 775,000 | 7.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 743,124 | 6.9M $ | as of Mar 31, 2026 |
| Retirement Planning Co of New England, Inc. | 651,148 | 6.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 626,699 | 5.8M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 590,269 | 5.5M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 554,802 | 5.2M $ | as of Mar 31, 2026 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 506,033 | 4.4M $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 480,000 | 4.5M $ | as of Mar 31, 2026 |
| TUDOR INVESTMENT CORP ET AL | 443,109 | 4.1M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 439,952 | 4.1M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 436,950 | 4.1M $ | as of Mar 31, 2026 |
Declared shareholders of Zevra Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 5.50 % | 3,211,877 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Zevra Therapeutics Inc". https://titelia.com/en/stocks/zevra-therapeutics-inc-US4884452065